{"result": "(\"entity\"<|>NUTRICIÓN PARENTERAL TOTAL<|>EVENT<|>Total parenteral nutrition (TPN) is a medical treatment used for the patient to provide nutrition intravenously when oral intake is not possible.)\n##\n(\"entity\"<|>INSULINA GLARGINA<|>EVENT<|>Insulin Glargine is a long-acting insulin used for managing blood sugar levels in the patient during their treatment.)\n##\n(\"entity\"<|>INSULINA RÁPIDA<|>EVENT<|>Rapid-acting insulin is used as a rescue medication for the patient to control blood sugar spikes.)\n##\n(\"entity\"<|>METFORMINA<|>EVENT<|>Metformin is a medication prescribed to the patient for managing type 2 diabetes, which was eventually discontinued after achieving good glycemic control.)\n##\n(\"entity\"<|>CONTROL GLUCÉMICO<|>EVENT<|>Glycemic control refers to the management of blood sugar levels, which was monitored and adjusted during the patient's treatment.)\n##\n(\"entity\"<|>IMC<|>EVENT<|>Body Mass Index (BMI) is a measure used to assess the patient's weight status in relation to height, indicating obesity levels.)\n##\n(\"entity\"<|>ANÁLISIS<|>EVENT<|>The analysis refers to the various medical tests conducted to monitor the patient's health status, including blood sugar and cholesterol levels.)\n##\n(\"relationship\"<|>PACIENTE<|>NUTRICIÓN PARENTERAL TOTAL<|>The patient was placed on total parenteral nutrition due to complications following surgery<|>7)\n##\n(\"relationship\"<|>PACIENTE<|>INSULINA GLARGINA<|>The patient used Insulin Glargine for managing blood sugar levels during treatment<|>8)\n##\n(\"relationship\"<|>PACIENTE<|>INSULINA RÁPIDA<|>The patient utilized rapid-acting insulin as a rescue medication for blood sugar control<|>8)\n##\n(\"relationship\"<|>PACIENTE<|>METFORMINA<|>The patient was prescribed Metformin for managing type 2 diabetes, which was later discontinued<|>7)\n##\n(\"relationship\"<|>PACIENTE<|>CONTROL GLUCÉMICO<|>The patient underwent monitoring of glycemic control throughout their treatment<|>8)\n##\n(\"relationship\"<|>PACIENTE<|>IMC<|>The patient's Body Mass Index (BMI) was assessed to evaluate obesity levels<|>6)\n##\n(\"relationship\"<|>PACIENTE<|>ANÁLISIS<|>The patient underwent various analyses to monitor health parameters during treatment<|>6)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: onda nasoentérica. Dado que el débito del drenaje había\n    aumentado en los últimos días, se decide de acuerdo con cirugía, realizar una nueva\n    colocación de sonda nasoentérica vía endoscópica a lo que la paciente se niega rotun-\n    damente.\n\n\n\n             Ante esta situación, se inicia nutrición parenteral total (NPT), que se mantiene\n    hasta el comienzo de la tolerancia oral. Tras comprobar el descenso del débito del dre-\n    naje se realiza nuevo tránsito comprobándose el cierre del trayecto fistuloso, con lo que\n    se reinicia la dieta oral de forma progresiva, siendo dada de alta la paciente al mes de\n    su intervención.\n\n\n\n             Al alta, se encuentra estable hemodinámicamente y asintomática, desde el\n    punto de vista digestivo. Durante el ingreso, el control glucémico fue adecuado tanto\n    con NET como con NPT. Con NET se utilizó insulina Glargina subcutánea con pauta de\n    rescate con insulina rápida y durante la NPT se ajustó insulina rápida en la bolsa de\n    NPT, con pauta de rescate subcutánea en función de los controles. La paciente es dada\n    de alta solamente con metformina con excelente control glucémico. En la primera revi-\n    sión ambulatoria presenta: glucosa 136 mg/dl, Hb A1c 6,6%. Resto de estudio normal. Su\n    peso en ese momento era de 97,5 Kilos con IMC 36,2 kg/m². El porcentaje de sobrepeso\n    perdido era del      49,76%. Se mantiene la metformina.\n\n\n\n58\n---\n         En la siguiente revisión la paciente: Peso 79,2 kilos, talla 164 cm, IMC 29,44 kg/m².\nPorcentaje de sobrepeso perdido 68,9%.\n         Aporta la siguiente analítica:\n         Glucosa 115 mg/dl, colesterol 189 mg/dl, HDL 53 mg/dl, LDL 116 mg/dl, triglicéridos\n98 mg/dl.\n         Parámetros nutricionales: proteínas 7g/dl, albúmina 3,9 g/dl, prealbúmina 25 mg/dl.\n         Hb A1c 5,9%.\n         Estudio de anemia: normal.\n         Se retira metformina.\n         En resumen, se trata de una paciente con obesidad mórbida y diabetesmellitus\ntipo 2 con mal control metabólico, intervenida de cirugía bariátrica y que presenta\nserias complicaciones en el postoperatorio.\n\n\n\nDiscusión\n         La cirugía bariátrica es una técnica ampliamente aceptada para el tratamiento\nde la obesidad. En adultos, en el momento actual las indicaciones son las siguientes:\n         Edad comprendida entre 18 - 60 años.\n         IMC igual o superior a 40 kg/m² o IMC > de 35 kg/m² con patologías asociadas a\nla obesidad como es el caso de la diabetes.\n         Pacientes con obesidad mantenida al menos durante 5 años y que los distintos\ntratamientos conservadores para pérdida de peso debidamente controlados hayan\nfracasado.\n         Ausencia de trastorno endocrinometabólico responsable de su obesidad.\n         Ausencia de psicopatología y adicción a sustancias que implique una contrain-\ndicación absoluta.\n         El tubo digestivo tiene un importante papel en la regulación del metabolismo,\nde ahí que esté considerado un órgano diana de vital importancia para el manejo de la\ndiabetes tipo 2. Numerosos trabajos han demostrado que la cirugía metabólica obtie-\nne excelentes resultados en el control glucémico y en la reducción de los factores de\nriesgo cardiovascular. El estudio STAMPEDE, realizado en pacientes obesos con diabe-\ntes tipo 2 intervenidos de cirugía bariátrica y seguidos durante 5 años, nos demuestra\ncomo la cirugía bariátrica + tratamiento médico intensivo es más efectiva que el trata-\nmiento médico intensivo de manera aislada para el control de la diabetes. Los efectos\nbeneficiosos sobre el control glucémico son duraderos, se mantienen durante 5 años\nincluso en pacientes con obesidad moderada (IMC entre 27 - 34 kg/m²) y esto conlleva\nuna reducción significativa en el uso de fármacos, tanto para la diabetes como para el\ncontrol de otros factores de riesgo cardiovascular1  .\n\n\n\n                                                                                                59\n---\n             Un posicionamiento reciente de la Federación Internacional de Diabetes (IDF),\n    establece que la cirugía metabólica debe ser recomendada para tratar la diabetes tipo\n    2 en paciente con obesidad mórbida (IMC igual o mayor de 40 kg/m²) y en aquellos con\n    obesidad grado 2 (IM\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>PACIENTE<|>PERSON<|>The patient is a person who underwent bariatric surgery due to morbid obesity and type 2 diabetes, experiencing complications post-operation.)\n##\n(\"entity\"<|>OBESIDAD MÓRBIDA<|>EVENT<|>Morbid obesity is a medical condition that the patient suffers from, leading to the need for surgical intervention.)\n##\n(\"entity\"<|>DIABETES MELLITUS TIPO 2<|>EVENT<|>Type 2 diabetes is a chronic condition that affects the way the body processes blood sugar, which the patient has alongside obesity.)\n##\n(\"entity\"<|>CIRUGÍA BARIÁTRICA<|>EVENT<|>Bariatric surgery is a procedure performed on the patient to aid in weight loss and improve metabolic control.)\n##\n(\"entity\"<|>FEDERACIÓN INTERNACIONAL DE DIABETES<|>ORGANIZATION<|>The International Diabetes Federation (IDF) is an organization that provides guidelines and recommendations for diabetes treatment, including the use of metabolic surgery for type 2 diabetes in obese patients.)\n##\n(\"relationship\"<|>PACIENTE<|>OBESIDAD MÓRBIDA<|>The patient suffers from morbid obesity, which necessitated surgical intervention<|>8)\n##\n(\"relationship\"<|>PACIENTE<|>DIABETES MELLITUS TIPO 2<|>The patient has type 2 diabetes, which is a significant health issue related to their obesity<|>8)\n##\n(\"relationship\"<|>PACIENTE<|>CIRUGÍA BARIÁTRICA<|>The patient underwent bariatric surgery to address their morbid obesity and type 2 diabetes<|>9)\n##\n(\"relationship\"<|>CIRUGÍA BARIÁTRICA<|>DIABETES MELLITUS TIPO 2<|>Bariatric surgery is a treatment option for patients with type 2 diabetes and obesity<|>7)\n##\n(\"relationship\"<|>FEDERACIÓN INTERNACIONAL DE DIABETES<|>CIRUGÍA BARIÁTRICA<|>The IDF recommends metabolic surgery for treating type 2 diabetes in patients with morbid obesity<|>6)\n<|COMPLETE|>"}]}